Home / Environment / Baltic Sea Chokes on Pharmaceuticals
Baltic Sea Chokes on Pharmaceuticals
28 Sep
Summary
- Pharmaceuticals like ibuprofen and diclofenac contaminate the Baltic Sea.
- Pollution stems from household waste, hospitals, and production sites.
- Solutions involve better prescribing and proper disposal of unused medicines.

The Baltic Sea, one of the world's most polluted bodies of water, is now grappling with significant pharmaceutical contamination. Commonly used drugs, including paracetamol, ibuprofen, and diclofenac, have been identified in its ecosystem. This pollution enters the sea through various pathways, such as wastewater from homes and hospitals, industrial discharges, and agricultural runoff.
A collaborative effort by researchers from Sweden, Finland, Lithuania, and Latvia emphasizes that managing this issue extends beyond improving wastewater treatment. They advocate for a comprehensive look at the entire lifecycle of medicines. This includes doctors considering environmental impacts when prescribing and encouraging patients to return unused medications to pharmacies rather than discarding them improperly.
Pharmaceuticals can persist in the Baltic Sea for extended periods, with some taking years to break down. Concerns are rising not about direct harm to swimmers, but about the impact on marine life. These drugs can cause feminization in fish and frogs and reduce the energy available for filter feeders like mussels, potentially destabilizing the delicate ecosystem.
Experts suggest that optimizing drug prescriptions and usage could significantly curb pollution. This involves choosing environmentally friendlier alternatives when clinically appropriate and avoiding unnecessary prescriptions. Simultaneously, increasing public awareness and accessibility for returning unused medicines to pharmacies is crucial. These combined strategies aim to reduce the overall pharmaceutical load on the Baltic Sea.